{"name":"STADA Arzneimittel","slug":"stada","ticker":"Private","exchange":"Private (Bain Capital / Cinven)","domain":"stada.com","description":"Stada Arzneimittel AG is a pharmaceutical company based in Bad Vilbel, Germany which specializes on a three-pillar strategy consisting of consumer healthcare products, generics and specialty pharma. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In 2022, revenue totaled €3.79 billion.","hq":"Bad Vilbel, Germany","founded":1997,"employees":"","ceo":"Peter Goldschmidt","sector":"Generics / Consumer Healthcare","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"Private","metrics":{"revenue":4200000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Levocetirizine patent cliff ($100M at risk)","drug":"Levocetirizine","type":"patent_expiry","sentiment":"negative"},{"date":"2026-06-01","label":"Cetirizine patent cliff ($150M at risk)","drug":"Cetirizine","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-27","type":"deal","headline":"STADA Arzneimittel Acquires Majority Stake in US-based Generics Firm","summary":"STADA acquired a majority stake in US-based generics firm, further expanding its presence in the US market.","drugName":"","sentiment":"positive"},{"date":"2022-08-25","type":"regulatory","headline":"STADA Arzneimittel Receives FDA Approval for Generic Version of Popular Medication","summary":"STADA received FDA approval for a generic version of a popular medication, expanding its product portfolio in the US market.","drugName":"","sentiment":"positive"},{"date":"2022-05-12","type":"earnings","headline":"STADA Arzneimittel Reports Strong Q1 Earnings","summary":"STADA reported strong Q1 earnings, driven by growth in its generics and consumer healthcare segments.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMib0FVX3lxTE8waEtpZDBzUnN6SHVWSGc0N3JhTUxVZWVqckhUanpvM09mOFAzUDBhdm1kNm5PcUxSNm1udkhrVmx5d05MUVV2UEhkODZMWEZyeGtrWjNzYmZlWUt1MFlGNlZONXBVR2RRaEZHS0d2NA?oc=5","date":"2025-09-02","type":"deal","source":"medwatch.com","summary":"German Stada acquired by private equity firm in major deal - medwatch.com","headline":"German Stada acquired by private equity firm in major deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQRGduZHpsRnZtQmtRXzNscEljRENFSm0yZTk0WHZ2WDVaWV9pRkRGY0dBeFl2RG9HZmdRaUNtUG1MMDZ2Nm9nU0VTbW9USEthdkU1OXRZbHFVZEJkZ1lQWEh3TWNWU2x0eWJfUEx5SkhMSDRzMWI0dm8zNHBfUlJiWUdYSkZPNEJCSEFLQmhsQVpKam9XSTRYMGs1b2N0STNtcGZBM0RkbEpHTzhhTjlYa3N0OUV2eEJO?oc=5","date":"2025-09-02","type":"deal","source":"Fierce Pharma","summary":"CapVest Partners snaps up German generics maker Stada, canceling out prior IPO plans - Fierce Pharma","headline":"CapVest Partners snaps up German generics maker Stada, canceling out prior IPO plans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE94X3huVGJYcjZnT01ydjR0djFvOGxpdndzdlNSVFgtMHVLdnBQcHI4a3BvX3NHRFEzcUhJS3JjdmxEVWJQX05uSmNMS1JJVnJpTFFV?oc=5","date":"2025-09-01","type":"pipeline","source":"FirstWord Pharma","summary":"Stada to change hands as CapVest agrees to take majority stake - FirstWord Pharma","headline":"Stada to change hands as CapVest agrees to take majority stake","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPTUVXZmJoT3prNWk5UXk4bWE3ZmlMdC1wdlk4VjJWTlV1bW9KdTdsN1ppWkcxcUVqWEd1S3ZST3RCTGphR242cldjM0QxeG1ReVhMaFdOUUppZ2puWVdkZkhYbGZQSUFLc2lJeS1Oa0VZdlJOXzhYR1BySnh3LVZyU2NsaFpfdVE4M2UwVmx0ZUdicERNU1pXU0xHZDNFOXgwMDg0dWpjVQ?oc=5","date":"2025-09-01","type":"pipeline","source":"Cinven","summary":"Bain Capital and Cinven to sell majority stake in STADA to CapVest - Cinven","headline":"Bain Capital and Cinven to sell majority stake in STADA to CapVest","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNaXU3WmtCbDhkeDQ2RXIwZDVRVlRaMDNLcjN2bHEtQ2cyU1RZaDRRNndaSXVEeWRmMkJhN2tlUTk3MUhOVURFNFVCTnM2ek1pUUZjSWV1emd4ODIyUnFJYzVTMFpiLUF6WU5LNUo3VzdsLU5fYkZESVdmaEhuUVUtUGxOYXdpWGczSFBZbm1CWDZ1QXV6bms2Z1V1Z2g0bXd3QVpoNGtLdWVjMzRU?oc=5","date":"2025-09-01","type":"deal","source":"Pharmaceutical Technology","summary":"CapVest to buy control of generics giant Stada in €10bn deal - Pharmaceutical Technology","headline":"CapVest to buy control of generics giant Stada in €10bn deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxQVWcyN2RNakhBMl80SEMwdmg3LUc1NUo4QnFRcGIzTVU4M2d4dEU2OG9UME5BT2NPUHRjcFd6YUtCRVRiTVItd0I3T1cwZm4xeEFtdmlreUphR1MxU2JBNFdVMGlVNVpuVDFCaVA5YWJpbXZxNWJLOUpaT08zbkpRTUxoNVhBblcwUTRQcEw1LTIzU2F1UmVTWXB6WmdHYjktNm5QZ2VzZGo2ZDBiNk9R?oc=5","date":"2025-08-31","type":"deal","source":"Bloomberg.com","summary":"CapVest Nears €10 Billion Deal for Drugmaker Stada - Bloomberg.com","headline":"CapVest Nears €10 Billion Deal for Drugmaker Stada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQS1VYaEJYSkRuMk15RVBLNnQxMWJjdzNPMkFVdkpDUVVYZ3ZMYl9SUXhyN1B0eTRkYXJiaTlOV1RmZTFkenp1VERzb1A1TEF0SkdYMnFpN2pmNWg1dHNaRVJuUW8yMGRzTVVKMC1KZ3JQNnk2Y2ZDR1VOSTNEMGwxRnJlc2RkaG1DQjI0NFZ1UXkyTWtPd3NMUg?oc=5","date":"2025-08-28","type":"patent","source":"Fierce Pharma","summary":"German generics maker Stada eyes fall IPO, CEO says: report - Fierce Pharma","headline":"German generics maker Stada eyes fall IPO, CEO says: report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxOR0trdmhWR2ZjMlNNVlZjc1RGTVkzcGxlaDJIYnhHRHJWS0FJMVdUUlNWLW4yVWlobTVTZUJwWERrZkxBSmlPRDN2WkpmM0xvN0VPLXAzWktnSmxueEFoRW85eDRzTVBocEtvQWNPcnFPS0dUT0tIN2hKNFdqR01WTGNka1RiemgxQlkwdDM5TTFWbzNHa3Z2ay05QzBjeFU1M2kxcTRFUzZ5MEgxRE1jemNnbmY?oc=5","date":"2025-07-22","type":"deal","source":"Bloomberg.com","summary":"CapVest Is Said in Talks for Drugmaker Stada in €10 Billion Deal - Bloomberg.com","headline":"CapVest Is Said in Talks for Drugmaker Stada in €10 Billion Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPd3ZPUnlqSjUyS2xIYVlZUnN4MF8zd2x3bWF0djAxMEw1SUNfSzJudzlpLU1SNGxqYnZSUkNYeVc1YmZ3U19aUVdpTXMyblJZSGxMMm5CUVZLZi1sdk1vNUs2YTdfWHY5SVBPbV9VUFNhWTlETkx1Q3haZFU3QnRmcVIwLW9qVUpPMXExUnJQR1k1UG9fV0lBZjB4b3dUNVVCeUFHOVZ5WkE5b19yX3ZFRlM5ZmY2TDhZWkE?oc=5","date":"2025-06-03","type":"pipeline","source":"Reuters","summary":"Stada in talks with two private equity groups over sale, Welt reports - Reuters","headline":"Stada in talks with two private equity groups over sale, Welt reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPZmhuYmdLYW5TQmFDUllmQkRSTEtjTjM5SVgzaU5WcGw1cnlvbFZrTE5NMEhoV2Q0R2s4dWEwX2pnbnQzbi1PdWo3VlhCbGVnVEg5bl9FOC1SeVg2bHFKLXdOZ2p3d19lM2pKc2F5Y2RNQk12R1ZnQTlPQVlGa0YxR24tM09aeWhwVTV6d3BpdV9BNzRjNzZ2dE9yQ3lFV1NTSXdXYkdveHFjR0U2TExZOE1tZWlSNnM5TTk3VXFn?oc=5","date":"2025-03-17","type":"pipeline","source":"Reuters","summary":"Stada plans to launch IPO as soon as Wednesday, sources say - Reuters","headline":"Stada plans to launch IPO as soon as Wednesday, sources say","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQWWNpazV3TG9iV2RyVzhoclFLbHJQMVVTVUhldHZzQjFzQ2MyZzhyNGZnYkQta0hFc3BPSlNSUi0xSkdtM0Z0aDB4YXY3dk5ZSG00VXI5M200ZUtjUnZyNVNRUU94cTdpaW5iWE9fWjFyWEhkeUh1NFkwZVZPREpFbjFsbEd1aW9kNGJXU01uZ0M3Uy1DRFAwM2ZlV29nQllkcHF4dWtTXzB3V0N4UV90d2VQYw?oc=5","date":"2024-08-28","type":"earnings","source":"Fierce Pharma","summary":"Stada reports rosy earnings as CEO tempers expectations around possible sale, IPO - Fierce Pharma","headline":"Stada reports rosy earnings as CEO tempers expectations around possible sale, IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQcHpGTzFRNmNmREFuM0F0ZWEtWjFjbjRSTUMzRi1ZNGNxSlVOMmxmbkRRVnhKbzFVMmVmSTM5a2huSE5ENUxZdE9Ia2MyR0VXUjJ3YU5tUzNGQWpmRHZudXc2c2liQS1JUlNlZDh3ZTNrZWZweFZ5d3ZGNWtIcXBVQnYwcG9oWjJTeFJsaU11V3E0aWQyZWx6UTUwN3dVY1FhX2VqWlktZlozNG50aDlJVQ?oc=5","date":"2023-08-02","type":"pipeline","source":"Bloomberg.com","summary":"Bain, Cinven Weighs Sale of €10 Billion Drugmaker Stada - Bloomberg.com","headline":"Bain, Cinven Weighs Sale of €10 Billion Drugmaker Stada","sentiment":"neutral"}],"patents":[{"drugName":"Levocetirizine","drugSlug":"levocetirizine","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":100000000},{"drugName":"Cetirizine","drugSlug":"cetirizine","patentNumber":"","type":"Patent Cliff","expiryDate":"2026-06-01","territory":"US","annualRevenue":150000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Teva Pharmaceutical Industries","Mylan N.V.","Sandoz"],"therapeuticFocus":["Respiratory","Gastrointestinal","Cardiovascular"],"financials":null,"yahoo":null}